Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Peladawnon Aug 05, 2024 1:20pm
64 Views
Post# 36164794

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Oncolytics Biotech Inc. has filed a Follow-on Equity Offerin

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Oncolytics Biotech Inc. has filed a Follow-on Equity OfferinTrump is going to win in November, unless the Demautocratic Party steals the election again (in the name of democracy of course), and things will immediately start to get better for everyone....fuel prices will drop dramatically, therefore inflation will start to ease, the border will revert back to sanity, easing the the present overwhelming strain on the country's medical and educational programs, Trump will return the crippling sanctions on Iran and therefore drastically weaken their ability to wage war on Israel, (like when he was in office last time) and he will put an end once and for all on their nuclear weapon program, and he will also impose crippling sanctions on Russia, drastically weakening Puten's ability to wage war on Ukraine or on any other country (like when he was in office last time)....and these are just to name only a few of the many ways things will begin to much better for  everyone.
<< Previous
Bullboard Posts
Next >>